医学全在线
医学全在线首页-开云app安装不了怎么办 -药师-护士-卫生资格-高级职称-考试题库-网校-考研-图谱-下载-招聘  
分类
国家级省级浙江省各省杂志
科技核心北大核心CSCDCSCD扩展
工具
期刊知识写作指导 论文投稿推荐期刊
期刊验证论文检测 录用通知往期目录
SCI
SCI指导影响因子
期刊点评基金动态
其它
经济教育计算机
建筑体育农业
北京|天津|河北|山西|湖北|江苏|安徽|山东|上海|浙江|江西|福建|湖南|宁夏|内蒙古|河南
四川|重庆|贵州|云南|辽宁|吉林|广东|广西|海南|陕西|甘肃|新疆|青海|卫生部直属|黑龙江|兵团
您现在的位置: 医学全在线 > 医学论文 > 论文投稿 > 正文:编码大鼠Nogo受体mRNA的shRNA重组腺病毒载体的构建和鉴定
    

医学论文范文:编码大鼠Nogo受体mRNA的shRNA重组腺病毒载体的构建和鉴定

来源:本站原创 更新:2013-9-12 论文投稿平台

医学论文范文:编码大鼠Nogo受体mRNA的shRNA重组腺病毒载体的构建和鉴定

【摘要】  目的: 构建Nogo受体(NgR)特异性shRNA重组腺病毒载体,为应用基因沉默技术从转录后水平进行缺血性脑损伤的基因治疗研究奠定基础. 方法: 将前期构建的大鼠Nogo受体mRNA的shRNA特异性真核表达载体pGenesil1shRNA的表达启动子U6连同shRNA亚克隆至穿梭质粒pAdTrack,酶切及DNA测序鉴定后, 将含NgR基因的重组穿梭质粒pAdTrackU6shRNA经PmeI线性化后转化入pAdEasy1感受态细菌. 将pAdU6shRNA质粒经PacI线性化后转染293细胞,包装重组腺病毒AdenoU6shRNA,并进行PCR鉴定、PCR产物测序及病毒滴度测定. 结果: 结果证实pAdTrackU6shRNA及pAdU6shRNA质粒构建正确,收获病毒后的PCR及DNA测序结果证明AdenoU6shRNA包被成功. 结论: 成功构建了大鼠Nogo受体mRNA的shRNA重组腺病毒载体AdenoU6shRNA,将为应用基因沉默技术研究NgR在缺血性脑损伤后神经再生中的作用奠定基础.

【关键词】  Nogo受体;RNA干扰;腺病毒

Construction and identification of recombinant adenovirus expressing the shRNA of rat Nogo66 receptor

ZHANG QinLi1, QIN XinYue1, YIN Cheng1, PENG Yan2

1Department of Neurology, First Affiliated Hospital, 2Department of Histology and Embryology, Chongqing Medical University, Chongqing 400016, China医.学.全.在.线www.lindalemus.com

【Abstract】 AIM: To construct the recombinant adenovirus vector of shRNA targeted to the rat Nogo66 receptor gene for the therapy of ischemic brain injury in posttranscriptional regulation. METHODS: The used pGenesil1shRNA was construsted and identified in previous experiment. The U6 and shRNA of pGenesil1shRNA were subcloned to pAdTrack. The product pAdTrackU6shRNA was linearized by Pme I to mediate homologous recombination with pAdEasy1 in pAdEasy1 host bacteria. The positive clone was identified by enzyme digestion, PCR analysis and DNA sequence analysis. After linearized by Pac I, the recombinant adenovirus DNA pAdU6shRNA was transfected into 293 cells for packaging and amplification of AdenoU6shRNA. AdenoU6shRNA was further identified by PCR analysis and DNA sequence analysis. RESULTS: PCR analysis, enzyme digestion and DNA sequence analysis proved the pAdTrackU6shRNA and the pAdU6shRNA had been successfully constructed. After being packaged in 293 cells, the recombinant adenovirus AdenoU6shRNA was identified by PCR analysis and DNA sequence analysis. CONCLUSION: We have successfully constructed recombinant adenovirus AdenoU6shRNA targeted against the rat Nogo66 receptor gene. It will be helpful to use RNAi in the research of the role of NgR in neural regeneration after cerebral ischemic injury.

【Keywords】 Nogo66 receptor; RNAi; adenoviruses

0引言

缺血性脑损伤后中枢神经的再生是神经康复难以逾越的障碍,近来研究发现,中枢神经再生困难的原因是CNS三种轴突再生抑制蛋白的存在,它们是NogoA,MAG和OMgp,与共同的受体NgR结合,激活下游信号及GTPase Rho系统,导致轴突生长锥崩溃[1]. 因此,NgR成为理想的治疗靶. RNA干扰(RNAi)是由双链RNA介导的、在转录后mRNA水平关闭相应基因表达过程-将与靶基因同源的21~23 bp的双链RNA导入细胞,它在细胞中可与靶基因mRNA结合,并迅速将其降解,从而抑制该基因的表达的过程[2].而成功地进行RNAi的关键在于使siRNA导入细胞,我们利用前期实验已构建的NgR shRNA真核表达载体,进一步构建腺病毒表达载体,通过病毒载体导入NgR siRNA沉默NgR基因,从而达到拮抗NgR基因的效应,促进神经再生.


[1] [2] [3] [4] [5] 下一页

...
关于我们 - 联系我们 -版权申明 -诚聘英才 - 网站地图 - 网络课程 - 帮助
医学全在线 版权所有© CopyRight 2006-2046,
浙ICP备12017320号
百度大联盟认证绿色会员实名网站 360认证可信网站 中网验证
Baidu
map